<DOC>
	<DOCNO>NCT02392767</DOCNO>
	<brief_summary>The effect combination product ( Verum ) L-arginine , Pycnogenol , vitamin K2 , R- ( + ) -alpha-lipoic acid vitamin B6 , B12 folic acid investigate double blind placebo-controlled cross-over study . Volunteers hypertension hyperhomocysteinemia randomly assign dietary supplement placebo .</brief_summary>
	<brief_title>Effect L-Arginine Pycnogenol Light Moderate Hypertension Endothelial Function</brief_title>
	<detailed_description>25 patient include trial . Intervention period 4 week 2 month wash phase . The screen visit volunteer study start include volunteer information , signature inform consent , anamnesis , medical history , ECG blood routine analysis . Efficacy parameter measure visit 1 , 2 , 3 , 4 . Endothelial function postprandial endothelial Reaction test use EndoPAT ( validate diagnosis tool ) . Blood pressure measure volunteer period 7 day visit . As additional parameter homocysteine ADMA ( assymmetric dimethyl arginine ) determed . For safety evaluation AEs ( Adverse Events ) , CC ( compliance control ) , tolerability , blood routine parameter vital sign assess .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K 2</mesh_term>
	<mesh_term>Pycnogenols</mesh_term>
	<criteria>borderline blood pressure ( systolic 130149 ) homocystein level &gt; 10Âµmol/l e.g . BMI &lt; 20kg/m2 &gt; 32kg/m2 use antihypertensive , anticoagulant , statin cardiovascular disease e.g . stroke , myocardial infarction use Larginine dietary supplement</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>L-Arginine</keyword>
	<keyword>Pycnogenol</keyword>
	<keyword>vitamin K2</keyword>
	<keyword>vitamin B</keyword>
	<keyword>endothelial function</keyword>
	<keyword>hypertension</keyword>
	<keyword>Homocystein &gt; 10</keyword>
</DOC>